World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
72
Citations
31328
World Ranking
19754
National Ranking
720

Overview

Otto Visser is affiliated with VU University Medical Center in the Netherlands. Their research primarily covers the field of Medicine, with a significant focus on Oncology, Pathology and Forensic Medicine, Genetics, Hematology, and Public Health, Environmental and Occupational Health.

The scientist's work addresses multiple specialized topics within oncology and hematology. Key subjects include:

  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Global Cancer Incidence and Screening
  • Multiple and Secondary Primary Cancers
  • Viral-associated Cancers and Disorders
  • Acute Myeloid Leukemia Research

Otto Visser has contributed to various publications across several journals. Frequent publication venues include:

  • Blood Cancer Journal
  • European Journal of Cancer
  • Leukemia
  • Blood
  • British Journal of Haematology

Notable recent papers featuring Otto Visser's involvement are:

  • "Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands" (2020), The Lancet Oncology
  • "Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities" (2021), Cancer
  • "The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands" (2020), Journal of Hematology & Oncology
  • "Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study" (2020), European Journal of Cancer
  • "Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study" (2022), Blood

The scientist collaborates frequently with several coauthors, including:

  • Avinash G. Dinmohamed
  • Marie José Kersten
  • Eduardus F. M. Posthuma
  • Pieternella J. Lugtenburg
  • Marcel Nijland

Best Publications

  • Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

    Claudia Allemani;Tomohiro Matsuda;Veronica Di Carlo;Rhea Harewood

  • Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.

    J. Ferlay;M. Colombet;I. Soerjomataram;T. Dyba

  • Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study

    Roberta De Angelis;Milena Sant;Michel P Coleman;Silvia Francisci

  • International incidence of childhood cancer, 2001-10 a population-based registry study

    Eva Steliarova-Foucher;Murielle Colombet;Lynn A G Ries;Florencia Moreno

  • Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project

    Milena Sant;Claudia Allemani;Carmen Tereanu;Roberta De Angelis

  • Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study

    Gemma Gatta;Laura Botta;Silvia Rossi;Tiiu Aareleid

  • Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

    Michael Schaapveld;Berthe M.P. Aleman;Anna M. van Eggermond;Cécile P.M. Janus

  • Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands.

    Avinash G Dinmohamed;Avinash G Dinmohamed;Otto Visser;Rob H A Verhoeven;Marieke W J Louwman

  • Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project

    C.A. Stiller;A. Trama;D. Serraino;S. Rossi

  • Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend Analysis

    David Palma;Otto Visser;Frank J. Lagerwaard;Jose Belderbos

  • Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study

    Gemma Gatta;Riccardo Capocaccia;Laura Botta;Sandra Mallone

  • Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.

    Milena Sant;Pamela Minicozzi;Morgane Mounier;Lesley A Anderson

  • Incidence of Cancer in the Netherlands 1998

    O. Visser;Jan Willem W. Coebergh;Sabine Siesling;J.A.A.M. van Dijck

  • Radiation Exposure From Pediatric CT Scans and Subsequent Cancer Risk in the Netherlands

    Johanna M. Meulepas;Cécile M. Ronckers;Anne M.J.B. Smets;Rutger A.J. Nievelstein

  • Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: Experience of two decades of cancer registry

    Catharina M. Korse;Babs G. Taal;Marie-Louise F. van Velthuysen;Otto Visser

  • Gender differences in stage-adjusted bladder cancer survival.

    N. Aydin Mungan;Katja K.H. Aben;Mark P. Schoenberg;Otto Visser

  • Changing incidence and improved survival of gliomas

    Vincent K.Y. Ho;Jaap C. Reijneveld;Roelien H. Enting;Henri P. Bienfait

  • Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells

    Abdulbaqi Al-toma;Otto J. Visser;Hyacintha M. van Roessel;B. Mary E. von Blomberg

  • Incidence, survival and prevalence of myeloid malignancies in Europe

    O. Visser;A. Trama;M. Maynadie;C. Stiller

  • Incidence of cancer in the Netherlands.

    O. Visser;J.W.W. Coebergh;L.J. Schouten;J.A.A.M. Dijck

Frequent Co-Authors

Flora E. van Leeuwen
Flora E. van Leeuwen Antoni van Leeuwenhoek Hospital
Jan Willem Coebergh
Jan Willem Coebergh Erasmus University Rotterdam
Chris J. J. Mulder
Chris J. J. Mulder Amsterdam UMC
Sonja Zweegman
Sonja Zweegman Amsterdam UMC
Jan J. Cornelissen
Jan J. Cornelissen Erasmus University Rotterdam
Pieter Sonneveld
Pieter Sonneveld Erasmus University Rotterdam
Franco Berrino
Franco Berrino Fondazione IRCCS Istituto Nazionale dei Tumori
Charles A. Stiller
Charles A. Stiller Public Health England
Diego Serraino
Diego Serraino University of Oxford
Eva Ardanaz
Eva Ardanaz Instituto de Salud Pública de Navarra

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering careers in Medicine or healthcare, there are diverse online pathways to expand your skills and credentials. Whether you wish to focus on clinical practice, healthcare administration, or a specialized sector, online programs offer flexible learning options to suit various interests and schedules.

If you are passionate about nutrition and health, the best online food science degree programs provide comprehensive education in food safety, metabolism, and diet planning. Those interested in healthcare leadership may consider cahme-accredited online Master of Healthcare Administration programs, which ensure quality and industry-recognized standards.

Registered nurses can advance their careers through online rn to bsn programs without clinicals, offering a streamlined route to a bachelor's degree. For nursing professionals aiming for the highest level of clinical practice, the shortest dnp programs provide an accelerated path to a Doctor of Nursing Practice.

Exploring these related online degrees can open new opportunities in medicine, healthcare administration, and beyond, with flexible formats supporting today’s busy learners.

Best Scientists Citing Otto Visser

Trending Scientists

Recently Published Articles